HIStalk | Healthcare IT News and Opinion - Part 11
the only remaining board member, has expressed strong interest in taking the company private amidst declining revenue and a sharp drop in valuation, which has plummeted from $3.5 billion to under $200 million. 23andMe is also facing $30 million ...